Amgen

Founder: George Rathmann
CEO: Robert A. Bradway 
CIO: Mike Zahigian

Amgen harnesses the power of biology and technology to combat the world’s most challenging diseases and enhance the quality of life for people around the globe. As a leader in biotechnology, Amgen excels in discovering, developing, manufacturing, and delivering groundbreaking medicines. With over 40 years of pioneering the biotech industry, Amgen continues to push the boundaries of science and technology, utilizing advanced tools and human genetic data to drive innovation.

Our commitment to research and development has resulted in a dynamic pipeline of treatments addressing a range of conditions, including cancer, heart disease, osteoporosis, inflammatory diseases, and rare disorders. Amgen's efforts are reflected in our position as a key player in the Dow Jones Industrial Average® and the Nasdaq-100 Index®, showcasing our role as one of the largest and most forward-thinking non-financial companies listed on the Nasdaq Stock Market.